Bd announces results for 2020 first fiscal quarter lowers fiscal 2020 guidance

Bd announces results for 2020 first fiscal quarter; lowers fiscal 2020 guidance.sees fy 2020 adjusted earnings per share $11.90 to $12.10.q1 earnings per share $0.87.q1 revenue $4.225 billion versus refinitiv ibes estimate of $4.18 billion.q1 earnings per share estimate $2.63 -- refinitiv ibes data.q1 adjusted earnings per share $2.65.sees fy 2020 revenue up 1.5 to 2.5 percent.becton dickinson - lowering fy 2020 revenue, adjusted eps guidance to reflect impact of remediation effort,anticipated loss of sales of alaris infusion system.becton dickinson - continuing to work with u.s. federal drug administration (fda) on its software remediation plan for alaris system.expects to submit its comprehensive regulatory filing in q4 of fiscal year 2020.in interim, will partner with fda and existing customers to ensure continued access to alaris system under medical necessity.becton dickinson - "stand behind safety of alaris system".fy2020 earnings per share view $12.56, revenue view $18.04 billion -- refinitiv ibes data.
BDX Ratings Summary
BDX Quant Ranking